TMRW Biorepositories are the Only Fertility
Cryostorage Facilities in the United
States Offering Digital Specimen Management, RFID Tracking,
ISO Certification & Automated Storage – Reducing Potential
Points of Failure by 94%
Inaugural Colorado Biorepository Partners
Include Leading Fertility Networks CCRM Fertility
& Pinnacle Fertility
NEW
YORK, June 26, 2024 /PRNewswire/ -- TMRW Life
Sciences, Inc. (TMRW), creator of the only FDA-cleared automated
specimen management and storage platform for frozen human sperm,
eggs and embryos, today announced the opening of a state-of-the-art
cryostorage facility in Colorado.
The biorepository in Boulder is
TMRW's second location alongside one in New York City in a growing network of offsite
cryostorage offerings that use the world's first automated
platforms for the safe management and storage of frozen
specimens.
More than 5 million frozen eggs and embryos are now stored at
fertility clinics around the United
States in legacy biorepositories using antiquated systems
prone to human error. Fertility clinics are running out of space
and in need of digital specimen management and offsite storage
solutions to reduce operational inefficiencies as well as the risks
of mix-ups, errors, loss, and lawsuits.
However, the traditional offsite storage model no longer works
for modern fertility clinics. TMRW is different by design with a
fully integrated digital platform that reduces paperwork, improves
operational efficiencies, provides real time specimen visibility,
and supports the clinic-patient relationship. TMRW's systems use
some of the most important improvements in cryostorage of the
21st century, including RFID-enabled tracking and
tracing, EMR integration, digital chain of custody and audit
trails, and coordination with lab witnessing products.
TMRW's inaugural partners at the new biorepository in
Boulder include two of the
nation's leading fertility clinic networks, CCRM Fertility and
Pinnacle Fertility.
"At Pinnacle Fertility, we prioritize the safety and success of
our patients' fertility journeys, and TMRW's advanced technology,
operational capabilities, and dedication to reducing potential
points of failure provide an unprecedented level of security and
reliability for our patients," shares Beth
Zoneraich, CEO of Pinnacle Fertility. "TMRW has been an
exceptional partner, seamlessly integrating their innovative
technology into our platform, elevating the service and care we
provide to our patients."
"From the team to the technology to the operations, TMRW's
biorepository is impressive and unparalleled in our field," said
William Schoolcraft, Founder and
Chief Medical Officer of CCRM Fertility. "I encourage every lab
director to experience first-hand TMRW's evolved inventory
management and storage offerings."
"With more than 250,000 specimens under management and growth
expected to continue doubling every year, TMRW's expansion into
Colorado and beyond is fueled by
high demand from patients and clinics alike," said Louis Villaba, Chief Executive Officer at
TMRW.
"TMRW's embryology teams, including those onsite at our
biorepositories and onsite in clinics digitizing legacy
inventories, have 180+ years of combined embryology, andrology
and/or lab experience," said Lori
Batta, Chief Operating Officer at TMRW. "They work in
lock-step with our fertility clinic partners as an extension of
their labs managing short- and long-term storage needs with a
logistics operation built to meet the dynamic nature of IVF
cycles."
The Boulder facility has
around-the-clock monitoring from TMRW's Overwatch system, which
provides tens of thousands of daily checks with remote monitoring
that alerts TMRW's dedicated team well before any problems might
arise. TMRW selected Boulder for
its low risk of earthquakes, fires, tornadoes, hurricanes, and
natural disasters. It is also an easy transportation hub in a state
with strong legislative and judicial support for reproductive
rights.
"Shipping eggs, sperm and embryos to offsite storage facilities
is a routine and remarkably safe aspect of fertility care," said
Michael Collins, Executive Director,
Scientific Affairs & Clinical Development at TMRW. "The
addition of continuous telemetry with TMRW improves specimen safety
by proactively identifying and mitigating any environmental
excursion that may damage or harm specimens."
TMRW's digital platform offers leading data security measures.
TMRW's software is HIPAA compliant and offers military-grade
security, SOC II compliance, and ISO 27001 / 27018 / 13485 and
HITRUST certifications.
Now partnered with more than 60 leading fertility clinics and
networks in the United States and
United Kingdom, TMRW is rapidly
becoming the new standard of care.
About TMRW Life Sciences
Founded in 2018, TMRW Life
Sciences, Inc., is a fertility technology company digitizing the
IVF lab starting with the world's first and only automated
platforms for the safe management and storage of frozen sperm, eggs
and embryos. For the first time, frozen specimens can be digitally
identified and tracked, safely managed with automated robotics, and
remotely monitored around the clock. TMRW's next-generation
technology platforms set a new standard of care, reducing potential
points of failure by 94% compared to manual systems. TMRW delivers
peace of mind by helping reduce the risk of specimen mix-up,
damage, or loss. Named Fast Company's #1 Most Innovative Biotech
company in 2022, TMRW has been adopted by leading clinics
across the United States and United Kingdom.
Learn more at tmrwlifesciences.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tmrw-life-sciences-expands-network-of-state-of-the-art-cryostorage-facilities-for-frozen-sperm-eggs-and-embryos-in-colorado-302183129.html
SOURCE TMRW Life Sciences
